PT-141 / Bremelanotide
Price range: $95.00 through $332.50
PT-141 / Bremelanotide
Bremelanotide (PT-141) selectively activates MC3R/MC4R in the hypothalamus to modulate sexual desire via central dopaminergic stimulation. FDA-approved as Vyleesi® for hypoactive sexual desire disorder (HSDD) in premenopausal women. First centrally acting melanocortin-based sexual dysfunction therapeutic.
Product Specifications
| CAS Number | 189691-06-3 |
| Molecular Weight | 1025.18 Da |
| Molecular Formula | C₅₀H₆₈N₁₄O₁₀ |
| Purity | Peak Area by HPLC ≥95% |
| Form | Lyophilized |
| Storage | -20°C |
| Usage | Research use |
Amino Acid Sequence
One-Letter Code:
Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH (cyclic)
Three-Letter Code:
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Research Applications
- Application: Receptor binding
- Biomarker Target: Melanocortin Receptors (MC1-5R)
- Research Area: Endocrinology
- Sub-category: Melanocortin System & Pigmentation
Reconstitution & Storage
- Reconstitution: Reconstitute in sterile water or appropriate buffer to desired concentration.
- Storage: Store lyophilized product at -20°C. After reconstitution, aliquot and store at -20°C to -80°C. Avoid repeated freeze-thaw cycles.
- Stability: Lyophilized product is stable for 24 months when stored properly.
For research use only. Not for diagnostic or therapeutic use.
Safety Data Sheets & Documentation
Protocols & Support
Reconstitution Protocol
1. Briefly centrifuge the vial to collect lyophilized powder at the bottom.
2. Reconstitute in sterile deionized water or PBS to a concentration of 0.2–1.0 mg/mL.
3. Gently pipette up and down to dissolve. Do not vortex.
4. Aliquot and store at -20°C to -80°C. Avoid repeated freeze-thaw cycles.
Download Data Sheet
Complete product data sheet including batch-specific QC data, sequence information, and storage guidelines.
Download PDF Data Sheet